GMP COMPLIANT MANUFACTURING PROCESS DEVELOPMENT OF ONCOLYTIC VIROTHERAPY

溶瘤病毒 溶癌病毒 过程开发 过程(计算) 计算机科学 制造工程 癌症研究 工程类 医学 肿瘤细胞 操作系统
作者
Takashi Okazaki
出处
期刊:Cytotherapy [Elsevier BV]
卷期号:26 (6): S217-S217
标识
DOI:10.1016/j.jcyt.2024.03.439
摘要

Background & Aim Development of oncolytic virotherapy for cancer treatment is attracting great concerns as a next-generation innovative modality. Oncolytic virotherapy usually utilize genetically modified virus that is designed to multiply only in cancer cells for safety. Conducting clinical trials as well as pre-clinical studies requires large quantities of high quality viruses as to GMP. Here we present the key considerations regarding GMP compliant process development of manufacturing oncolytic virus, Coxsackie virus type B3 (CVB3), designed for clinical trial targeting triple-negative breast cancer. CVB3 is a non-enveloped, linear single-strand RNA virus, and sizing approximately 27 to 33 nm diameter. Methods, Results & Conclusion Here we will discuss the key considerations we have gained during the manufacturing process development from the initial model using a zonal rotor centrifugal separator to the later developed systems including tangential flow filtration system and ion chromatography. Later developed system consists of all process, from upstream cell culture expansion to downstream target purification, being designed as fully closed and single-use manufacturing system. In brief, HEK293 cell suspension extended in 3L serum-free medium infected with CVB3, made total 150 mL of final products as 8.43 x 10 exp7 TCID50/mL concentration. Quality analysis of products related impurities as residual human cell protein and remnant DNA/RNA was also confirmed to be within FDA recommended standards. Thus the GMP compliant manufacturing process of oncolytic virus we established considered to be suitable for technology transfer for future commercial production. Development of oncolytic virotherapy for cancer treatment is attracting great concerns as a next-generation innovative modality. Oncolytic virotherapy usually utilize genetically modified virus that is designed to multiply only in cancer cells for safety. Conducting clinical trials as well as pre-clinical studies requires large quantities of high quality viruses as to GMP. Here we present the key considerations regarding GMP compliant process development of manufacturing oncolytic virus, Coxsackie virus type B3 (CVB3), designed for clinical trial targeting triple-negative breast cancer. CVB3 is a non-enveloped, linear single-strand RNA virus, and sizing approximately 27 to 33 nm diameter. Here we will discuss the key considerations we have gained during the manufacturing process development from the initial model using a zonal rotor centrifugal separator to the later developed systems including tangential flow filtration system and ion chromatography. Later developed system consists of all process, from upstream cell culture expansion to downstream target purification, being designed as fully closed and single-use manufacturing system. In brief, HEK293 cell suspension extended in 3L serum-free medium infected with CVB3, made total 150 mL of final products as 8.43 x 10 exp7 TCID50/mL concentration. Quality analysis of products related impurities as residual human cell protein and remnant DNA/RNA was also confirmed to be within FDA recommended standards. Thus the GMP compliant manufacturing process of oncolytic virus we established considered to be suitable for technology transfer for future commercial production.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wade发布了新的文献求助10
1秒前
1秒前
2秒前
花藏影完成签到,获得积分10
3秒前
慕青应助平常毛衣采纳,获得10
5秒前
浮游应助州府十三采纳,获得10
5秒前
6秒前
7秒前
灵巧的导师完成签到,获得积分10
7秒前
shgd完成签到,获得积分10
9秒前
zwy发布了新的文献求助10
12秒前
wade完成签到,获得积分10
12秒前
15秒前
隐形曼青应助闭眼玩手机采纳,获得10
15秒前
量子星尘发布了新的文献求助10
16秒前
小蘑菇应助pingli19861002采纳,获得10
17秒前
17秒前
20秒前
飘飘玲应助刘恒宇采纳,获得10
20秒前
alooof发布了新的文献求助10
23秒前
23秒前
pcr163应助QinLi采纳,获得50
23秒前
斯文败类应助小熊同学采纳,获得30
23秒前
俭朴的发带完成签到,获得积分10
26秒前
ccob完成签到,获得积分10
27秒前
gezhao发布了新的文献求助10
28秒前
29秒前
哆啦的空间站应助北彧采纳,获得20
30秒前
大宝剑2号完成签到,获得积分10
30秒前
CodeCraft应助淡定树叶采纳,获得10
31秒前
32秒前
33秒前
无所谓发布了新的文献求助10
34秒前
香蕉觅云应助磐xst采纳,获得10
34秒前
星宿完成签到,获得积分10
35秒前
37秒前
平常毛衣发布了新的文献求助10
37秒前
38秒前
39秒前
思源应助frankk采纳,获得10
40秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Zeolites: From Fundamentals to Emerging Applications 1500
Encyclopedia of Materials: Plastics and Polymers 1000
Architectural Corrosion and Critical Infrastructure 1000
Early Devonian echinoderms from Victoria (Rhombifera, Blastoidea and Ophiocistioidea) 1000
Hidden Generalizations Phonological Opacity in Optimality Theory 1000
Handbook of Social and Emotional Learning, Second Edition 900
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 内科学 生物化学 物理 计算机科学 纳米技术 遗传学 基因 复合材料 化学工程 物理化学 病理 催化作用 免疫学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 4920227
求助须知:如何正确求助?哪些是违规求助? 4191881
关于积分的说明 13019681
捐赠科研通 3962699
什么是DOI,文献DOI怎么找? 2172183
邀请新用户注册赠送积分活动 1190075
关于科研通互助平台的介绍 1098875